The Journal of Organic Chemistry
Article
9.25 (1H, d, J = 9.6 Hz); 1H NMR (500 MHz, TFA−CDCl3) δ −2.85
(1H, s), −1.87 (1H, v br), −0.16 (1H, s), −0.15 (1H, s), 1.62 (3H, t,
J = 7.7 Hz), 1.65−1.69 (6H, two overlapping triplets), 3.32 (3H, s),
3.37 (3H, s), 3.43 (3H, s), 3.78−3.85 (4H, two overlapping quartets),
3.90 (2H, q, J = 7.7 Hz), 8.45 (1H, t, J = 9.6 Hz), 8.58 (2H, t, J = 9.6
Hz), 9.47 (1H, s), 9.48 (1H, s), 9.94−9.98 (2H, two overlapping
doublets), 10.33 (1H, s), 10.35 (1H, s); 13C NMR (CDCl3) δ 10.6,
10.8, 10.9, 16.3, 16.5, 17.1, 18.9, 19.1, 19.2, 92.94, 92.98, 107.6, 126.1,
131.6, 134.7, 139.4, 139.8, 141.6, 146.4, 148.5; 13C NMR (TFA−
CDCl3) δ 11.2, 11.5, 11.6, 16.07, 16.15, 16.4, 19.6, 19.9, 20.1, 94.9,
95.4, 109.7, 110.0, 123.9, 128.00, 128.04, 135.8, 139.1, 140.38, 140.42,
140.9, 141.8, 142.38, 142.45, 142.51, 144.2, 145.0, 145.6, 146.4, 147.4,
148.1, 148.9, 153.83, 153.89; HRMS (FAB) calcd for C35H35N3 + H
498.2909, found 498.2911.
8.26 (1H, s), 8.66 (1H, s), 9.06 (1H, s), 9.15 (1H, d, J = 10.7 Hz), 9.20
(1H, d, J = 10.5 Hz), 9.28 (1H, s); H NMR (500 MHz, TFA−
1
CDCl3) δ −2.91 (2H, s), −0.35 (1H, s), 0.89 (1H, br), 1.27 (1H, br),
1.59 (3H, t, J = 7.7 Hz), 1.66 (3H, t, J = 7.8 Hz), 1.73 (9H, s), 3.31
(3H, s), 3.32 (3H, s), 3.71−3.80 (4H, two overlapping quartets), 8.51
(1H, t, J = 7.4 Hz), 8.62 (1H, t, J = 7.5 Hz), 8.89 (1H, dd, J = 1.9, 10.3
Hz), 8.95 (1H, dd, J = 1.9, 10.6 Hz), 9.58−9.61 (3H, m), 9.91 (1H, d,
J = 10.5 Hz), 9.97 (1H, d, J = 10.8 Hz), 10.07 (1H, s), 10.32 (1H, s)
10.41 (1H, s); 13C NMR (CDCl3) δ 10.8, 11.1, 16.2, 16.5, 18.9, 19.1,
31.9, 39.1, 90.1, 97.3, 106.7, 111.5, 119.5, 119.8, 122.4, 125.6, 126.7,
126.8, 128.76, 128.83, 129.9, 134.4, 134.6, 135.2, 136.6, 137.9, 138.8,
139.2, 139.9, 141.1, 142.4, 143.0, 143.8, 164.9; 13C NMR (TFA−
CDCl3) δ 11.1, 11.2, 16.0, 16.1, 19.7, 19.9, 31.5, 37.2, 41.9, 105.6,
106.8, 111.8, 118.0, 123.6, 124.7, 128.5, 131.9, 132.3, 135.0, 135.7,
136.7, 139.3, 139.5, 139.7, 141.2, 141.5, 141.6, 142.1, 142.7, 142.8,
144.0, 145.1, 147.7, 150.6, 153.0, 153.5, 155.8, 156.9, 174.9; HRMS
(EI) calcd for C41H40N2 560.3191, found 560.3197. Anal. Calcd for
C41H40N2·1/10CHCl3: C, 86.20; H, 7.06; N, 4.89. Found: C, 86.19; H,
6.89; N, 5.07.
13,17-Diethyl-12,18-dimethyl-22-carbabenzo[g]-
azuliporphyrin (44a). Dipyrrole dicarboxylic acid 18a (30 mg, 0.094
mmol) was dissolved in TFA (5 mL) and then diluted with
dichloromethane (150 mL). Fulvene dialdehyde 37a (30 mg, 0.097
mmol) was added to the stirred solution, and the mixture was stirred
in the dark under nitrogen for 16 h. The solution was washed with
saturated sodium bicarbonate solution, dried over sodium sulfate, and
evaporated under reduced pressure. The residue was loaded onto a
grade 3 alumina column and eluted with 50% dichloromethane−
chloroform. A bright green fraction was collected and the solvent
evaporated. Recrystallization from chloroform−hexanes gave the
dicarbaporphyrinoid (9.0 mg, 0.018 mmol, 19%) as dark green
crystals: mp >300 °C; UV−vis (free base in 1% Et3N−CHCl3) λmax
(log ε) 368 (4.76), 401 (4.67), 470 (4.68), 496 (4.65), 659 nm (4.09);
UV−vis (monocation 44aH+ in 0.5% TFA−CHCl3) λmax (log ε) 314
(4.51), 373 (4.80), 471 (4.60), 522 (sh, 4.40), 690 nm (4.50); UV−vis
23-tert-Butyl-12,13,17,18-tetramethyl-22-carbabenzo[g]-
azuliporphyrin (44c). Using the previous procedure, dipyrryl-
methane 18b (27 mg, 0.094 mmol) was reacted with fulvene
dialdehyde 37b (30 mg, 0.082 mmol). Recrystallization from
chloroform−hexanes gave the dicarbaporphyrinoid (20 mg, 0.037
mmol, 46%) as a dark green powder: mp >300 °C; UV−vis (1%
Et3N−CHCl3) λmax (log ε) 368 (4.77), 398 (4.67), 470 (4.70), 492
(4.70), 626 (sh, 4.10), 677 nm (4.15); UV−vis (0.1% TFA−CHCl3)
λmax (log ε) 375 (4.83), 474 (4.64), 522 (infl, 4.44), 692 nm (4.55);
UV−vis (5% TFA−CHCl3) λmax (log ε) 382 (4.79), 421 (4.89), 460
(sh, 4.55), 485 (sh, 4.42), 520 (4.24), 670 (sh, 4.24), 737 (4.76), 770
nm (4.41); 1H NMR (500 MHz, CDCl3) δ 1.15 (1H, br s), 1.58 (9H,
s), 2.76 (3H, s), 2.80 (3H, s), 2.87 (6H, s), 3.00 (1H, v br), 7.49−7.54
(3H, m), 7.80 (2H, d, J = 10.5 Hz), 8.02 (1H, s), 8.14−8.17 (1H, m),
8.34−8.37 (1H, m), 8.58 (1H, s), 9.12 (1H, d, J = 10.5 Hz), 9.18−9.21
(2H, m); 1H NMR (500 MHz, TFA−CDCl3) δ −2.72 (2H, s), −0.18
(1H, s), 1.72 (9H, s), 3.20 (3H, s), 3.25 (3H, s), 3.27 (6H, s), 8.47
(1H, t, J = 7.4 Hz), 8.59 (1H, t, J = 7.4 Hz), 8.82 (1H, d, J = 10.1 Hz),
8.88 (1H, d, J = 10.6 Hz), 9.53 (1H, s), 9.54−9.57 (2H, m), 9.86 (1H,
d, J = 10.3 Hz), 9.91 (1H, d, J = 10.6 Hz), 9.97 (1H, s), 10.26 (1H, s),
10.33 (1H, s); 13C NMR (CDCl3) δ 10.6, 11.0, 11.3, 32.0, 39.1, 89.8,
97.4, 106.1, 111.4, 119.4, 119.8, 122.3, 125.4, 126.5, 126.5, 126.6,
128.9, 129.6, 132.3, 134.3, 134.5, 135.7, 136.2, 137.6, 139.4, 139.9,
142.3, 143.1, 143.4, 143.9, 164.8; 13C NMR (TFA−CDCl3) δ 11.3,
11.4, 11.5, 11.7, 31.7, 37.2, 105.6, 107.4, 111.7, 118.3, 123.5, 124.6,
129.1, 131.5, 132.1, 134.6, 135.4, 137.0, 138.5, 139.2, 139.4, 140.4,
140.9, 141.5, 142.0, 142.1, 142.5, 142.7, 143.9, 144.3, 147.6, 152,7,
153.6, 155.4, 157.3; HRMS (EI) calcd for C39H36N2 532.2879, found
532.2882. Anal. Calcd for C39H36N2·1/3CHCl3: C, 82.58; H, 6.40; N,
4.90. Found: C, 82.57; H, 6.29; N, 5.06.
2+
(dication 44aH2 in 5% TFA−CHCl3) λmax (log ε) 388 (4.79), 421
(4.83), 516 (sh, 4.26), 670 (infl, 4.14), 743 (4.64), 779 nm (infl, 4.36);
1H NMR (500 MHz, CDCl3) δ 1.48−1.53 (6H, two overlapping
triplets), 2.87 (3H, s), 2.89 (3H, s), 3.22 (2H, q, J = 7.7 Hz), 3.27 (2H,
q, J = 7.7 Hz), 3.44 (1H, br s), 7.49−7.56 (5H, m), 7.70 (1H, t, J = 9.7
Hz), 7.99 (1H, s), 8.14 (1H, d, J = 6.8 Hz), 8.35 (1H, d, J = 6.8 Hz),
1
8.56 (1H, s), 9.10 (1H, s), 9.15 (1H, s), 9.18 (1H, d, J = 9.8 Hz); H
NMR (500 MHz, TFA−CDCl3): δ −2.76 (2H, s), −0.08 (1H, s), 1.55
(3H, t, J = 7.7 Hz), 1.62 (3H, t, J = 7.7 Hz), 3.26 (3H, s), 3.29 (3H, s),
3.67−3.75 (4H, two overlapping quartets), 8.47 (1H, t, J = 7.5 Hz),
8.56−8.72 (4H, m), 9.51 (1H, s), 9.54 (1H, d, J = 8.1 Hz), 9.57 (1H,
d, J = 8.1 Hz), 9.95 (1H, d, J = 9.4 Hz), 9.99−10.01 (2H, overlapping
singlet and doublet), 10.32 (1H, s), 10.37 (1H, s); 13C NMR (TFA−
CDCl3) δ 11.1, 11.3, 16.0, 16.1, 19.6, 19.9, 105.7, 106.7, 111.9, 118.7,
123.6, 124.8, 129.4, 131.6, 131.9, 135.1, 135.3, 137.0, 140.0, 140.63,
140.67, 141.9, 142.1, 142.6, 142.8, 142.9, 143.5, 144.0, 144.8, 146.8,
147.9, 150.6, 154.1, 154.2, 156.6, 158.0; HRMS (EI) calcd for
C37H32N2 504.2565, found 504.2563.
23-tert-Butyl-13,17-diethyl-12,18-dimethyl-22-carbabenzo-
[g]azuliporphyrin (44b). Using the foregoing procedure, dipyrryl-
methane 18a (30 mg, 0.094 mmol) was reacted with fulvene dialde-
hyde 37b (30 mg, 0.082 mmol). Recrystallization from chloroform−
hexanes gave the dicarbaporphyrinoid (37 mg, 0.066 mmol, 80%) as a
dark green powder: mp >300 °C; UV−vis (free base, 1% Et3N−
CHCl3) λmax (log ε) 368 (4.78), 399 (4.68), 470 (4.70), 494 (4.70),
624 (sh, 4.10), 677 nm (4.16); UV−vis (monocation 44bH+, 0.1%
TFA−CHCl3) λmax (log ε) 314 (4.49), 376 (4.70), 418 (4.46), 473
(4.55), 522 (infl, 4.38), 692 nm (4.41); UV−vis (dication 44bH22+, 5%
TFA−CHCl3) λmax (log ε) 383 (4.79), 421 (4.89), 458 (sh, 4.55), 485
(sh, 4.42), 520 (sh, 4.25), 672 (sh, 4.25), 737 (4.76), 772 nm (sh,
4.40); 1H NMR (500 MHz, CDCl3) δ 1.15 (1H, br s), 1.49−1.54 (6H,
two overlapping triplets), 1.58 (9H, s), 2.90 (3H, s), 2.92 (3H, s), 3.03
(1H, br s), 3.25 (2H, q, J = 7.7 Hz), 3.30 (2H, q, J = 7.7 Hz), 3.74
(1H, v br), 7.49−7.55 (2H, m), 7.61 (1H, s), 7.80−7.82 (2H, m), 8.08
(1H, s), 8.17−8.19 (1H, m), 8.36−8.38 (1H, m), 8.65 (1H, s), 9.15
(1H, d, J = 10.7 Hz), 9.21 (1H, d, J = 10.7 Hz), 9.23 (1H, s); 1H NMR
(500 MHz, trace TFA−CDCl3) δ −1.13 (1H, br s), −0.36 (1H, br s),
1.51−1.57 (6H, two overlapping triplets), 1.59 (9H, s), 2.99 (3H, s),
3.00 (3H, s), 3.42−3.50 (4H, m), 3.74 (1H, v br), 7.38 (1H, t, J = 7.2
Hz), 7.44 (1H, t, J = 7.2 Hz), 7.96−8.00 (2H, m), 8.06−8.09 (1H, m),
23-tert-Butyl-13,17-bis(2-methoxycarbonylethyl)-12,18-di-
methyl-22-carbabenzo[g]azuliporphyrin (44d). Using the pre-
vious procedure, dipyrrylmethane 18c (41 mg, 0.10 mmol) was
reacted with fulvene dialdehyde 37b (30 mg, 0.082 mmol).
Recrystallization from chloroform−hexanes gave the dicarbaporphyr-
inoid (21 mg, 0.031 mmol, 38%) as a dark green powder: mp >300
°C; UV−vis (free base, 1% Et3N−CHCl3) λmax (log ε) 371 (4.80), 398
(sh, 4.70), 474 (4.72), 495 (4.72), 628 (sh, 4.13), 678 nm (4.20);
UV−vis (monocation, 0.1% TFA−CHCl3) λmax (log ε) 314 (4.51),
377 (4.81), 418 (4.51), 472 (4.63), 525 (infl, 4.43), 692 nm (4.55);
UV−vis (dication, 5% TFA−CHCl3) λmax (log ε) 385 (sh, 4.81), 423
(4.91), 461 (sh, 4.58), 486 (sh, 4.47), 520 (4.31), 670 (sh, 4.28),
1
735 nm (4.75); H NMR (500 MHz, CDCl3) δ 0.91 (1H, br s), 1.58
(9H, s), 2.73 (1H, br), 2.91 (2H, t, J = 7.8 Hz), 2.93 (6H, s), 2.94 (2H,
t, J = 7.8 Hz), 3.57 (2H, t, J = 7.8 Hz), 3.63 (2H, t, J = 7.8 Hz), 3.70
(3H, s), 3.71 (3H, s), 7.50−7.55 (2H, m), 7.59 (1H, br s), 7.83 (2H, d,
J = 10.5 Hz), 8.11 (1H, s), 8.17 (1H, d, J = 6.8 Hz), 8.36 (1H, d, J =
1
6.5 Hz), 8.64 (1H, br), 9.10−9.15 (1H, m), 9.18−9.23 (2H, m); H
NMR (500 MHz, TFA−CDCl3) δ −2.94 (2H, s), −0.39 (1H, s), 1.74
(9H, s), 3.07 (2H, t, J = 7.7 Hz), 3.12 (2H, t, J = 7.7 Hz), 3.33 (3H, s),
3.34 (3H, s), 3.750 (3H, s), 3.755 (3H, s), 4.11 (2H, t, J = 7.7 Hz),
2379
dx.doi.org/10.1021/jo2026977 | J. Org. Chem. 2012, 77, 2368−2381